9/14/2026 6:01:07 PM Generative AI Is Coming to Medical Devices. FDA Is Already Thinking About What Comes Next. By Jennifer German Imagine a medical device that can answer questions, summarize patient records, suggest next steps, and interact with users through a...
8/26/2026 6:37:23 PM 176 Womble Attorneys Recognized in 2027 Best Lawyers: Ones to Watch® in America By Ginny Gibson Andrew Yocopis Brandon Hellewell Daniel Salgado Daniel P. Crane Douglas Schorr Jack McCarthy Jon Brinkman Justin K. Gowan Katherine Costella Katie Rios Lucas Hickman Yi Wilkinson Madison Fox Nicolas T. Martino +12 more... Show less Womble Bond Dickinson (US) LLP is pleased to announce that 176 attorneys are recognized in the 2027 edition of Best Lawyers: Ones to...
8/21/2026 12:04:08 AM Best Lawyers® Honors 488 Womble Attorneys Across 2027 Editions By Womble Bond Dickinson Womble Bond Dickinson (US) LLP is pleased to announce that 313 attorneys are recognized in the 2027 edition of The Best Lawyers in...
7/16/2026 6:26:00 PM Science Doesn't Stand Still: Evolving Evidence and Expert Reliability Under Daubert By Gloria Malpass This is the second part in a “Law Meets Science” series on how the scientific record affects expert evidence in litigation. Part I...
6/17/2026 8:39:00 PM FDA Issues Draft Guidance Clarifying Use of Form FDA 3542 By Dana Severance The FDA has issued new draft Q&A guidance (available here) on Forms FDA 3542a and FDA 3542, providing additional clarity on Orange Book...
6/15/2026 4:46:00 PM What the Scientific Record Leaves Out: Unreported Evidence and Expert Reliability Under Daubert By Gloria Malpass This article is the first in a two-part “Law Meets Science” series on how the state of the scientific record can affect the reliability...
6/10/2026 4:17:00 PM What the Supreme Court’s Latest Decision on Skinny Labeling Means for Branded Drug Manufacturers By Dana Severance On June 4, 2026 in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the U.S. Supreme Court issued a unanimous decision that...
5/15/2026 4:28:00 PM From Farm to Fork: Understanding FDA’s Food Traceability By Jennifer German Traceability has become a central part of FDA’s approach to food safety, and manufacturers are starting to feel the impact.From farm to...
5/12/2026 6:09:00 PM Colorado Jury Finds Cambria Not Negligent, Products Not Defective in Silicosis Case By Womble Bond Dickinson Denver, CO (May 12, 2026) — In the case of Tyler Jordan and Caitlin Jordan v. Cambria Co. LLC, et al., Case No. 2024CV31180, a Denver,...
5/6/2026 3:24:00 PM Ruth Levy to Discuss Emerging Risks and Litigation Trends Involving Ultra-Processed Foods By Ruth Levy On June 10, Womble Bond Dickinson’s Ruth Levy will speak during a webinar examining the emerging health risks of ultra-processed foods...
4/28/2026 6:12:00 PM Celiac at the Table: Science, Risk, Liability By Eve Jomp A recent lawsuit, Bayton v. Olive Garden, illustrates legal risk for restaurants, creating the expectation of duty, reliance and...
4/9/2026 3:58:00 PM FDA’s 2026 General Wellness Policy and What It Means for Manufacturers of Wearable Devices By Jennifer German Wearable devices are products worn on the body that use sensors and software to collect and display health or lifestyle information such...
3/12/2026 6:28:00 PM Update for Big Food: FDA Announces New Policy on “No Artificial Colors” Labeling By Al Windham On February 5, 2026, the U.S. Food and Drug Administration (FDA) issued a letter to food manufacturers announcing a new enforcement...
3/11/2026 10:26:00 PM Interoperability Meets Litigation: What Epic v. Health Gorilla Means for Mass Torts By Chris Douglas The recently filed complaint in a California district court by Epic Systems and several large health systems against Health Gorilla and...
2/12/2026 3:43:00 PM Navigating New Hemp Laws: A Major Shift for the Cannabis Industry By Jennifer German A fast-growing market built on hemp-derived cannabinoid products is about to face a federal reset. Over the past several years, consumer...
1/15/2026 9:13:00 PM How the MAHA Commission Could Influence Pharmaceutical Marketing and Prescriber Education By Matt Quinn The Make America Healthy Again (MAHA) Commission, introduced in 2025, is shaping conversations about healthcare policy and industry...